Xtx Topco LTD Achilles Therapeutics PLC Transaction History
Xtx Topco LTD
- $1.81 Billion
- Q1 2025
A detailed history of Xtx Topco LTD transactions in Achilles Therapeutics PLC stock. As of the latest transaction made, Xtx Topco LTD holds 38,923 shares of ACHL stock, worth $57,606. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,923
Previous 26,824
45.11%
Holding current value
$57,606
Previous $30,000
90.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ACHL
# of Institutions
9Shares Held
5.55MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN3.8MShares$5.63 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA192KShares$283,9060.0% of portfolio
-
Brave Asset Management Inc10KShares$14,8000.0% of portfolio
-
Rhumbline Advisers Boston, MA4.48KShares$6,6300.0% of portfolio
-
Endurance Wealth Management, Inc.2KShares$2,9600.0% of portfolio
About Achilles Therapeutics plc
- Ticker ACHL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,774,000
- Market Cap $60.3M
- Description
- Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in ...